News Archive
Cancer patients dealing with the often painful and unrecognized impacts of chemotherapy and other treatment on the skin, hair and nails have a new place at George Washington University to turn to for help.
When chronic, unresponsive eruptions don't respond to standard treatments, think cutaneous T-cell lymphoma, says L. Frank Glass, MD in an interview with Adam Friedman, MD.
WASHINGTON (June 15, 2017) - The George Washington University (GW) Cancer Center is pleased to announce the opening of the Supportive Oncodermatology Clinic.
WASHINGTON (June 14, 2017) - Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment.
Congratulations to Jennifer Bires, LICSW, OSW-C, program coordinator of patient support services at the George Washington University (GW) Cancer Center. Bires will be named 2017 Oncology Social Worker of the Year at the Association of Oncology Social Work (AOSW) Annual Conference to be held May…
Congratulations to Aubrey Van Kirk Villalobos, M.P.H., M.Ed., director of cancer control and health equity at the Institute for Patient-Centered Initiatives and Health Equity at the George Washington University (GW) Cancer Center, who was part of the winning Urgent Wellness team from the
Dr. Kaltman spent time at Equinox Bethesda discussing the upcoming Force Fitness Fest and hereditary cancer prevention with Great Day Washington.
Adam Friedman, M.D., Associate Professor of Dermatology at the GW School of Medicine and Health Sciences, wrote an article for the Huffington Post on avoiding ultraviolet radiation.
Dr. Edward M. Sotomayor was a featured speaker on the Politico Pro Health Care series where the topic was drug safety. The panel discussed the future of the FDA in the new administration, drug effictiveness and more. Watch the full video here
Allison Harvey, MPH, CHES, of George Washington University, evaluates preliminary outcomes among primary care and oncology providers who took part in the Cancer Survivorship E-Learning Series (Abstract 78).